Doxorubicin-Loaded Tumor-Targeting Peptide-Decorated Polypeptide Nanoparticles for Treating Primary Orthotopic Colon Cancer.

Liu G, Wang M, He H, Li J

Open source

DOI
10.3389/fphar.2021.744811
Published
2021
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2021.744811,
  title = {Doxorubicin-Loaded Tumor-Targeting Peptide-Decorated Polypeptide Nanoparticles for Treating Primary Orthotopic Colon Cancer.},
  author = {Liu G and Wang M and He H and Li J},
  year = {2021},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2021.744811},
  url = {https://doi.org/10.3389/fphar.2021.744811}
}

RIS

TY  - JOUR
TI  - Doxorubicin-Loaded Tumor-Targeting Peptide-Decorated Polypeptide Nanoparticles for Treating Primary Orthotopic Colon Cancer.
AU  - Liu G
AU  - Wang M
AU  - He H
AU  - Li J
PY  - 2021
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2021.744811
UR  - https://doi.org/10.3389/fphar.2021.744811
ER  - 

APA

G, L., M, W., H, H., & J, L. (2021). Doxorubicin-Loaded Tumor-Targeting Peptide-Decorated Polypeptide Nanoparticles for Treating Primary Orthotopic Colon Cancer.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2021.744811

Source records